Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Recurrence × Clarithromycin × Clear all

Phase

Status

Withdrawn 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 6 Lymphoma 4 Stomach Neoplasms 3 Lymphoma, B-Cell, Marginal Zone 3 Dyspepsia 2 Recurrence 1 Peptic Ulcer 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, Large B-Cell, Diffuse 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, B-Cell 1 Gastritis 1 B-cell Malignancies 1

Interventions

Cyclophosphamide 56 Dexamethasone 44 Lenalidomide 32 Rituximab 29 Peripheral Blood Stem Cell Transplantation 28 fludarabine phosphate 25 Filgrastim 25 Bortezomib 25 Carboplatin 23 Radiotherapy 21 Etoposide 21 Melphalan 20 Paclitaxel 19 Busulfan 19 Whole-Body Irradiation 17 Gemcitabine 17 Cytarabine 17 Cyclosporine 17 pomalidomide 16 Mycophenolic Acid 16 Bevacizumab 16 pembrolizumab 15 fludarabine 15 Cisplatin 15 Methotrexate 12 Calcium Dobesilate 12 venetoclax 11 Tacrolimus 11 Nivolumab 11 Bendamustine Hydrochloride 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01516606 2022-08-12

HD-K

IRCCS San Raffaele

Phase 2 Completed

Lymphoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡